Back to top

AstraZeneca Advances AI-Driven Lung Cancer Risk Study in Brazil

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is backing a new lung cancer study that uses artificial ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AstraZeneca PLC (AZN)